Sickle cell anaemia

Written by

in

 

Sickle Cell Anemia: Molecular Pathology & Clinical Management

Sickle cell anemia (SCA) is an autosomal recessive hemoglobinopathy resulting from a structural point mutation in the β-globin gene. It represents a chronic, severe extravascular and intravascular hemolytic state characterized by recurrent vaso-occlusive crises and progressive systemic organ damage.

1. Molecular Pathophysiology

The genetic error is localized to codon 6 of the β-globin gene on chromosome 11, where a single nucleotide substitution changes the transcribed template:

  • The Amino Acid Shift: Glutamic acid (hydrophilic/charged) is replaced by Valine (hydrophobic/nonpolar). This creates mutant Hemoglobin S (HbS: $\alpha_2\beta^S_2$).
  • Polymerization Dynamics: Under conditions of deoxygenation, hypoxia, dehydration, or acidosis, the hydrophobic valine residues interact to form long, rigid, fibrous polymers. This deforms the red blood cell into its classic crescent/sickle shape.
  • Reversibility & Destruction: Initially, sickling is reversible upon reoxygenation. However, repeated cycles damage the plasma membrane, leading to irreversibly sickled cells that are prematurely destroyed by splenic macrophages (extravascular hemolysis) and within the vasculature (intravascular hemolysis), reducing the lifespan of a red blood cell from 120 days down to roughly 10–20 days.

2. Acute Vaso-Occlusive Manifestations

Rigid, deformed sickle cells express increased adhesion molecules, causing them to stick to endothelial walls and clog microvascular beds, inducing downstream ischemia and infarction:

Crisis Type Clinical Features High-Yield Management Pearls
Dactylitis Symmetrical, agonizing swelling of the hands and feet. Occurs in infants (6 months to $2$ years old) because small bones in extremities still contain active hematopoiesis. Often, the initial presenting sign of SCA. Managed with aggressive hydration and analgesia.
Acute Chest Syndrome (ACS) Fever, chest pain, tachypnea, cough, and new pulmonary infiltrates on chest X-ray. Driven by pulmonary fat embolism or atypical infections. The leading cause of mortality in SCA patients. Requires emergent oxygen, empiric antibiotics (covering Chlamydia/Mycoplasma), and exchange transfusion.
Aplastic Crisis Sudden, severe drop in hemoglobin levels accompanied by a near-zero reticulocyte count (RPI < 1\%). Induced by Parvovirus B19 infection. Parvovirus temporarily halts marrow erythropoiesis. Differentiate from hyperhemolytic crisis by checking the reticulocyte count.
Splenic Sequestration Vaso-occlusion of splenic venous outflow leads to massive pooling of blood within the spleen, severe acute anemia, and hypovolemic shock. Seen primarily in toddlers. Emergency treatment involves volume resuscitation and swift splenectomy.

3. Chronic Complications & Functional Asplenia

Continuous microinfarctions cause progressive, irreversible systemic end-organ damage:

  • Autosplenectomy: Repeated splenic infarction causes the spleen to completely fibrose and shrink into a non-functional remnant by childhood. This leaves patients highly vulnerable to encapsulated organisms (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae).
  • Osteomyelitis: Increased risk of bone infections, classically caused by Salmonella species (due to gut microinfarctions leaking bacteria into circulating channels) as well as Staphylococcus aureus.
  • Renal Papillary Necrosis: The low-oxygen, hypertonic environment of the renal medulla promotes sickling, leading to microinfarcts that manifest as painless gross hematuria and sloughed papillae.

4. Confirmatory Diagnostics

  • Hemoglobin Electrophoresis / HPLC: Confirms the diagnosis. Sickle cell disease (HbSS) shows **0\% normal HbA**, highly elevated **HbS (85\text{–}95\% )**, and variably elevated HbF. Sickle trait (HbAS) displays roughly 55\text{–}60\% HbA and 35\text{–}40\% HbS.
  • Peripheral Blood Smear: Reveals characteristic crescent-shaped sickle cells (drepanocytes) and target cells. The presence of **Howell-Jolly bodies** (basophilic nuclear remnants within RBCs) indicates that functional asplenia has occurred.

5. Long-Term Management Protocols

  • Hydroxyurea: The primary disease-modifying pharmacotherapy. It acts by **increasing the production of Hemoglobin F (HbF: $\alpha_2\gamma_2$)**, which disrupts the polymerization of HbS, thereby reducing the frequency of painful vaso-occlusive crises.
  • Prophylaxis: Daily prophylactic oral penicillin is mandatory from birth until age 5 to prevent fatal pneumococcal sepsis. Comprehensive vaccination schedules against encapsulated strains are vital.